Younger patients with multiple myeloma can achieve durable survival
Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median progression-free survival (PFS) of approximately 3.5 years and a median overall survival (OS) of ...
Jul 27, 2023
0
23